{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:22:06Z","timestamp":1767993726857,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clon.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:16:29Z","timestamp":1689041789000},"page":"e573-e581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Short-course Palliative Hypofractionated Radiotherapy in Patients with Poor-prognosis High-grade Glioma: Survival and Quality of Life Outcomes from a Prospective Phase II Study"],"prefix":"10.1016","volume":"35","author":[{"given":"Y.","family":"Baviskar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Likonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mokal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clon.2023.07.001_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"12 Suppl 2","key":"10.1016\/j.clon.2023.07.001_bib2","article-title":"CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.clon.2023.07.001_bib3","doi-asserted-by":"crossref","first-page":"iii93","DOI":"10.1093\/annonc\/mdu050","article-title":"High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Stupp","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clon.2016.09.015","article-title":"Radiotherapy in glioblastoma: the past, the present and the future","volume":"29","author":"Gzell","year":"2017","journal-title":"Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2023.07.001_bib5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.21521","article-title":"Patterns of care in elderly glioblastoma patients","volume":"64","author":"Iwamoto","year":"2008","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.21037\/apm-20-1246","article-title":"Narrative review of palliative hypofractionated radiotherapy for high grade glioma","volume":"10","author":"Saeed","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00167068","article-title":"Prognostic factors for high-grade malignant glioma: development of a prognostic index. A report of the Medical Research Council Brain Tumor Working Party","volume":"9","year":"1990","journal-title":"J\u00a0Neurooncol"},{"issue":"9","key":"10.1016\/j.clon.2023.07.001_bib8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials","volume":"85","author":"Curran","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.clon.2023.07.001_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1470-2045(02)00853-7","article-title":"Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care","volume":"3","author":"Gupta","year":"2002","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clon.2023.07.001_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","article-title":"Validation and simplification of the radiation therapy oncology group recursive partitioning analysis classification for glioblastoma","volume":"81","author":"Li","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.clon.2023.07.001_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamaoncol.2016.6020","article-title":"Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG Oncology RTOG 0525","volume":"3","author":"Bell","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clon.2023.07.001_bib12","article-title":"Prognostic nomograms for primary high-grade glioma patients in adult: a retrospective study based on the SEER database","author":"Yang","year":"2020","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.21037\/apm-20-640","article-title":"Overview of prognostic factors in adult gliomas","volume":"10","author":"Sharma","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"4","key":"10.1016\/j.clon.2023.07.001_bib14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma: with particular reference to bronchogenic carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"issue":"669","key":"10.1016\/j.clon.2023.07.001_bib15","first-page":"73","article-title":"A\u00a0study of the effect of misonidazole in conjunction with radiotherapy for treatment of grades 3 and 4 astrocytoma. A report from the MRC Working Party on misonidazole in gliomas","volume":"56","year":"1983","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.clon.2023.07.001_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-005-7020-9","article-title":"Prospective study of quality of life in adults with newly diagnosed high-grade gliomas","volume":"76","author":"Brown","year":"2006","journal-title":"J\u00a0Neurooncol"},{"issue":"10","key":"10.1016\/j.clon.2023.07.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10100723","article-title":"Palliative care in high-grade glioma: a review","volume":"10","author":"Crooms","year":"2020","journal-title":"Brain Sci"},{"issue":"12","key":"10.1016\/j.clon.2023.07.001_bib18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14737140.2020.1828867","article-title":"Current clinical management of elderly patients with glioma","volume":"20","author":"Pellerino","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.clon.2023.07.001_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clon.2004.08.006","article-title":"Survival in high-grade glioma: a study of survival in patients unfit for or declining radiotherapy","volume":"17","author":"Prestwich","year":"2005","journal-title":"Clin Oncol"},{"issue":"15","key":"10.1016\/j.clon.2023.07.001_bib20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.clon.2023.07.001_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.clon.2023.07.001_bib22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2012","journal-title":"Lancet Oncol"},{"issue":"35","key":"10.1016\/j.clon.2023.07.001_bib23","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","article-title":"International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme","volume":"33","author":"Roa","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.clon.2023.07.001_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1215\/15228517-2008-050","article-title":"Health-related quality of life in patients with high-grade glioma","volume":"11","author":"Cheng","year":"2009","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5732\/cjc.013.10214","article-title":"Health-related quality of life in high-grade glioma patients","volume":"33","author":"Dirven","year":"2014","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.clon.2023.07.001_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/PROM.S179313","article-title":"Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma","volume":"10","author":"Rosenlund","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"issue":"3","key":"10.1016\/j.clon.2023.07.001_bib28","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.clon.2020.08.011","article-title":"Prospective longitudinal assessment of quality of life as activities of daily living as patient-reported outcome measures in recurrent\/progressive glioma treated with high-dose salvage re-irradiation","volume":"33","author":"Maitre","year":"2021","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2023.07.001_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/0973-1482.73353","article-title":"Assessment of compliance to treatment and efficacy of a resource-sparing hypofractionated radiotherapy regimen in patients with poor-prognosis high-grade gliomas","volume":"6","author":"Gupta","year":"2010","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"5","key":"10.1016\/j.clon.2023.07.001_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.clon.2023.07.001_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0973-1482.29826","article-title":"Translation and pilot validation of Hindi translation of assessing quality of life in patients with primary brain tumors using EORTC brain module (BN20)","volume":"2","author":"Budrukkar","year":"2006","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"3","key":"10.1016\/j.clon.2023.07.001_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11060-009-9939-8","article-title":"Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice","volume":"95","author":"Budrukkar","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2023.07.001_bib33","series-title":"The EORTC QLQ-C30 scoring manual","author":"Fayers","year":"2001"},{"issue":"1","key":"10.1016\/j.clon.2023.07.001_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-007-9487-z","article-title":"Prospective analysis of incidence of central nervous system tumors presenting in a tertiary cancer hospital from India","volume":"87","author":"Jalali","year":"2008","journal-title":"J\u00a0Neurooncol"},{"issue":"6","key":"10.1016\/j.clon.2023.07.001_bib35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/nop\/npaa033","article-title":"Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients","volume":"7","author":"Coomans","year":"2020","journal-title":"Neuro-oncol Pract"},{"issue":"4","key":"10.1016\/j.clon.2023.07.001_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11912-022-01210-6","article-title":"Easing the journey \u2013 an updated review of palliative care for the patient with high-grade glioma","volume":"24","author":"Crooms","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"10.1016\/j.clon.2023.07.001_bib37","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/neuonc\/noac097","article-title":"Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period","volume":"24","author":"Coomans","year":"2022","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.clon.2023.07.001_bib38","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/neuonc\/noab037","article-title":"Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients","volume":"23","author":"Dirven","year":"2021","journal-title":"Neuro-oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655523002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655523002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:53:06Z","timestamp":1760543586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655523002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0936655523002406"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2023.07.001","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-course Palliative Hypofractionated Radiotherapy in Patients with Poor-prognosis High-grade Glioma: Survival and Quality of Life Outcomes from a Prospective Phase II Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}